David M. Burger
Department of Clinical Pharmacy
Radboud University Nijmegen Medical Center and Nijmegen Institute for Infection
Inflammation and Immunity (N4i)
Nigmegen
Netherlands
Name/email consistency: high
- The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program. Burger, D., Teulen, M., Eerland, J., Harteveld, A., Aarnoutse, R., Touw, D. Ther. Drug. Monit (2011)
- Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies. Burger, D.M. Expert. Opin. Drug. Metab. Toxicol (2010)
- Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets. Burger, D., Ewings, F., Kabamba, D., L'homme, R., Mulenga, V., Kankasa, C., Thomason, M., Gibb, D.M., Chintu, C., Walker, A.S. Ther. Drug. Monit (2010)
- Drug-drug interactions with raltegravir. Burger, D.M. Eur. J. Med. Res. (2009)
- Drug interactions between statins and antiretroviral agents. Burger, D., Stroes, E., Reiss, P. Curr. Opin. HIV. AIDS (2008)
- The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe. Burger, D.M., Huisman, A., Van Ewijk, N., Neisingh, H., Van Uden, P., Rongen, G.A., Koopmans, P., Bertz, R.J. Clin. Pharmacol. Ther. (2008)
- Age-dependent pharmacokinetics of lamivudine in HIV-infected children. Burger, D.M., Verweel, G., Rakhmanina, N., Verwey-Van Wissen, C.P., La Porte, C.J., Bergshoeff, A.S., Lyall, H., Hartwig, N.G., Green, H., Soldin, S., Gibb, D.M., de Groot, R. Clin. Pharmacol. Ther. (2007)
- Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism. Burger, D., van der Heiden, I., la Porte, C., van der Ende, M., Groeneveld, P., Richter, C., Koopmans, P., Kroon, F., Sprenger, H., Lindemans, J., Schenk, P., van Schaik, R. Br. J. Clin. Pharmacol (2006)
- Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers. Burger, D.M., Agarwala, S., Child, M., Been-Tiktak, A., Wang, Y., Bertz, R. Antimicrob. Agents Chemother. (2006)
- Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children. Burger, D.M., Bergshoeff, A.S., De Groot, R., Gibb, D., Walker, S., Tréluyer, J.M., Hoetelmans, R.M. J. Pediatr. (2004)
- Therapeutic drug monitoring of nelfinavir in pregnancy: a case report. Burger, D.M., Grintjes, K.J., Lotgering, F.K., Koopmans, P.P. Ther. Drug. Monit (2004)
- Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients. Burger, D., Boyd, M., Duncombe, C., Felderhof, M., Mahanontharit, A., Ruxrungtham, K., Ubolyam, S., Stek, M., Cooper, D., Lange, J., Phanupak, P., Reiss, P. J. Antimicrob. Chemother. (2003)
- Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals. Burger, D., Hugen, P., Reiss, P., Gyssens, I., Schneider, M., Kroon, F., Schreij, G., Brinkman, K., Richter, C., Prins, J., Aarnoutse, R., Lange, J. AIDS (2003)
- A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study). Burger, D.M., Aarnoutse, R.E., Dieleman, J.P., Gyssens, I.C., Nouwen, J., de Marie, S., Koopmans, P.P., Stek, M., van der Ende, M.E. Antivir. Ther. (Lond.) (2003)
